Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function
Clinical trial NCT03040479 · COMPLETED
Trial details
- NCT number
- NCT03040479
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-14
- Primary completion
- 2017-07-17
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.